The poor prognosis of breast cancer is associated with HER2/neu protein overexpression due to HER2/neu gene amplification, which is similar to colon cancer, and HER2 amplification is used in the treatment of CRC as one of the mechanisms of cetuximab resistance [136, 137]. The gene discussed is ERBB2; the disease is colorectal carcinoma.